Greenwich Lifesciences Inc (GLSI)

$28.02 -3.95 (-12.36%)
Market Cap 416.62M
Revenue (ttm) 0.00
Net Income (ttm) -15.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 425,100
Avg Vol 621,682
Day's Range N/A - N/A
Shares Out 13.86M
Stochastic %K 48%
Beta 1.47
Analysts Strong Sell
Price Target $47.50

Company Profile

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy...

Industry: Biotechnology
Sector: Healthcare
Phone: 832 819 3232
Address:
Building 14, 3992 Bluebonnet Dr., Stafford, United States
TheinvestmetABCD
TheinvestmetABCD Feb. 4 at 3:27 AM
$GLSI Snahel went bought aggressively in December and January on the open market. His last purchase was on the 13th of January if I remember correct. If we don´t hear anything this month, we are in the blackout period and major news is imminent. Like I said, I am expecting this month a big partnership deal, but let´s see...
4 · Reply
Sanibelspeaks
Sanibelspeaks Feb. 4 at 2:49 AM
$GLSI unless you’re selling for nickels and dimes, the swings don’t matter at all- my gains are too high at this point anyway, but either way I’m not taking any chances I’m holding- this one is just a matter of time
0 · Reply
rangervs
rangervs Feb. 4 at 12:39 AM
$BKYI nice movement still adding on the dips $NUWE same $GLSI
0 · Reply
History101
History101 Feb. 3 at 8:39 PM
$IBRX I love when my portfolio is green on a DEEP RED market day. GLTALs!! $SLS $LQDA $GLSI
1 · Reply
Pmills1111
Pmills1111 Feb. 3 at 8:13 PM
$GLSI the fuckery
0 · Reply
WolfSK
WolfSK Feb. 3 at 7:29 PM
$GLSI tracking xbi. Chart looks identical. Hopefully back to 30 plus soon. GLA
0 · Reply
albert88
albert88 Feb. 3 at 7:23 PM
$GLSI Rebound
0 · Reply
mshah1615
mshah1615 Feb. 3 at 7:23 PM
$GLSI
1 · Reply
albert88
albert88 Feb. 3 at 7:21 PM
$GLSI House Passes Funding Bill to End Government Shutdown. Jobs Report Looks Like the Only Big Casualty.
0 · Reply
JeffTex
JeffTex Feb. 3 at 7:06 PM
$GLSI I kinda went out on a limb & bought 5k shares @ $27.20 for a swing trade. I hv 2k shares holding long term.
0 · Reply
Latest News on GLSI
Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy

Jan 27, 2026, 6:00 AM EST - 7 days ago

Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01

Jan 22, 2026, 6:00 AM EST - 12 days ago

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

Dec 29, 2025, 6:00 AM EST - 5 weeks ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Dec 22, 2025, 6:00 AM EST - 6 weeks ago

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?

Dec 15, 2025, 11:11 AM EST - 7 weeks ago

Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

Dec 15, 2025, 6:00 AM EST - 7 weeks ago

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

Dec 8, 2025, 6:00 AM EST - 2 months ago

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

Dec 3, 2025, 6:00 AM EST - 2 months ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

Oct 9, 2025, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium

Oct 2, 2025, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

Sep 30, 2025, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland

Sep 18, 2025, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland

Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track Designation

Sep 10, 2025, 6:00 AM EDT - 5 months ago

Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track Designation

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Aug 20, 2025, 9:25 AM EDT - 5 months ago

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

Aug 19, 2025, 6:00 AM EDT - 6 months ago

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

Aug 13, 2025, 6:00 AM EDT - 6 months ago

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Aug 11, 2025, 6:00 AM EDT - 6 months ago

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 3, 2025, 8:00 AM EDT - 10 months ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

Apr 2, 2025, 6:00 AM EDT - 11 months ago

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

Mar 27, 2025, 6:00 AM EDT - 11 months ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01

Mar 17, 2025, 6:45 AM EDT - 11 months ago

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

Feb 10, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe

Jan 29, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

Jan 27, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

Jan 23, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

Greenwich LifeSciences Provides Update on Commercial Manufacturing

Jan 22, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Commercial Manufacturing

Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI)

Jan 17, 2025, 8:20 AM EST - 1 year ago

Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

Jan 14, 2025, 6:15 AM EST - 1 year ago

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

Greenwich LifeSciences Partners with GIM in Italy

Nov 26, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Partners with GIM in Italy

Greenwich LifeSciences Provides Update on Corporate Events

Nov 18, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Corporate Events

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

Aug 1, 2024, 6:00 AM EDT - 1 year ago

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

Greenwich LifeSciences: Halting Of Breast Cancer Recurrence With GLSI-100

Jun 26, 2024, 2:05 PM EDT - 1 year ago

Greenwich LifeSciences: Halting Of Breast Cancer Recurrence With GLSI-100

Greenwich LifeSciences Set to Join Russell 2000 Index Again

Jun 26, 2024, 7:33 AM EDT - 1 year ago

Greenwich LifeSciences Set to Join Russell 2000 Index Again

Greenwich LifeSciences Announces $2.5 Million Private Placement

Jun 14, 2024, 6:00 AM EDT - 1 year ago

Greenwich LifeSciences Announces $2.5 Million Private Placement

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

Mar 13, 2024, 6:00 AM EDT - 2 years ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Mar 12, 2024, 6:00 AM EDT - 2 years ago

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

Feb 27, 2024, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

Feb 22, 2024, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Feb 14, 2024, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

Nov 21, 2023, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

Greenwich LifeSciences Provides Year End Update

Dec 29, 2022, 6:48 AM EST - 3 years ago

Greenwich LifeSciences Provides Year End Update

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023

Dec 1, 2022, 6:00 AM EST - 3 years ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023

Greenwich LifeSciences: Persevering CEO And Interesting Data

Sep 6, 2022, 5:40 PM EDT - 3 years ago

Greenwich LifeSciences: Persevering CEO And Interesting Data

Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial

Aug 11, 2022, 10:30 AM EDT - 3 years ago

Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial

Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial

Aug 3, 2022, 8:00 AM EDT - 3 years ago

Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial

Greenwich LifeSciences Provides Financing Strategy & Corporate Update

Jul 28, 2022, 6:00 AM EDT - 3 years ago

Greenwich LifeSciences Provides Financing Strategy & Corporate Update

Here's Why Greenwich Lifesciences Shares Are Popping Off Today

Jul 12, 2022, 1:18 PM EDT - 3 years ago

Here's Why Greenwich Lifesciences Shares Are Popping Off Today

Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed

Jul 12, 2022, 6:00 AM EDT - 3 years ago

Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed

Greenwich LifeSciences Announces Suspension of Share Repurchase Program

Jul 11, 2022, 4:15 PM EDT - 3 years ago

Greenwich LifeSciences Announces Suspension of Share Repurchase Program

Greenwich LifeSciences to Resume Stock Repurchase Program

May 23, 2022, 7:00 AM EDT - 4 years ago

Greenwich LifeSciences to Resume Stock Repurchase Program

TheinvestmetABCD
TheinvestmetABCD Feb. 4 at 3:27 AM
$GLSI Snahel went bought aggressively in December and January on the open market. His last purchase was on the 13th of January if I remember correct. If we don´t hear anything this month, we are in the blackout period and major news is imminent. Like I said, I am expecting this month a big partnership deal, but let´s see...
4 · Reply
Sanibelspeaks
Sanibelspeaks Feb. 4 at 2:49 AM
$GLSI unless you’re selling for nickels and dimes, the swings don’t matter at all- my gains are too high at this point anyway, but either way I’m not taking any chances I’m holding- this one is just a matter of time
0 · Reply
rangervs
rangervs Feb. 4 at 12:39 AM
$BKYI nice movement still adding on the dips $NUWE same $GLSI
0 · Reply
History101
History101 Feb. 3 at 8:39 PM
$IBRX I love when my portfolio is green on a DEEP RED market day. GLTALs!! $SLS $LQDA $GLSI
1 · Reply
Pmills1111
Pmills1111 Feb. 3 at 8:13 PM
$GLSI the fuckery
0 · Reply
WolfSK
WolfSK Feb. 3 at 7:29 PM
$GLSI tracking xbi. Chart looks identical. Hopefully back to 30 plus soon. GLA
0 · Reply
albert88
albert88 Feb. 3 at 7:23 PM
$GLSI Rebound
0 · Reply
mshah1615
mshah1615 Feb. 3 at 7:23 PM
$GLSI
1 · Reply
albert88
albert88 Feb. 3 at 7:21 PM
$GLSI House Passes Funding Bill to End Government Shutdown. Jobs Report Looks Like the Only Big Casualty.
0 · Reply
JeffTex
JeffTex Feb. 3 at 7:06 PM
$GLSI I kinda went out on a limb & bought 5k shares @ $27.20 for a swing trade. I hv 2k shares holding long term.
0 · Reply
yft212
yft212 Feb. 3 at 6:51 PM
$GLSI https://www.cnbc.com/2026/02/02/stock-market-today-live-updates.html Hey Merck, hope you have eyes on us.
0 · Reply
Whitevalkyrie01
Whitevalkyrie01 Feb. 3 at 6:31 PM
$GLSI amazing how a -2% nasdaq can take this down today but when nasdaq was up 100% in the last 3 years GLSI was static and flat a fk joke bro
1 · Reply
Alwaysdiversify
Alwaysdiversify Feb. 3 at 6:31 PM
$GLSI I am low on dry powder, but cobbled together enough to add 90 shares at $27.00. If Snehal has been buying recently in the upper $20S, then why shouldn't I follow in his wake?
1 · Reply
Katkimkimkim
Katkimkimkim Feb. 3 at 6:15 PM
$GLSI added 100 shares. I think people who pulled out at 30s will enter back in once we are in ticking uptrend again.
0 · Reply
LIGator
LIGator Feb. 3 at 6:09 PM
$GLSI Blue Horseshoe Loves GLSI. Time to buy more.
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Feb. 3 at 6:03 PM
$GLSI where is my green candle???
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Feb. 3 at 5:56 PM
$GLSI added again 200 at $27.10
0 · Reply
Rolltide2020
Rolltide2020 Feb. 3 at 5:51 PM
$GLSI Wasn't looking to add today, but they have me thinking about it now.
0 · Reply
Sanibelspeaks
Sanibelspeaks Feb. 3 at 5:51 PM
$GLSI there’s no volume, low float, easily manipulable- nothing to worry about thus far- this one simply a matter of time for three digits
0 · Reply
Xit4profit
Xit4profit Feb. 3 at 5:46 PM
$GLSI wtf? Why the drop?
1 · Reply
yft212
yft212 Feb. 3 at 5:34 PM
$GLSI Added another 145 shares today.
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Feb. 3 at 5:32 PM
$GLSI picked up another 300 at $28.20.
0 · Reply